Cargando…
BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan
Familial breast cancer is estimated to account for 15–20% of all cases of breast cancer. Surveillance for familial breast cancer is well-established world-wide. However, this service does not exist in Jordan, due to the scarcity of information with regard to the genetic profiling of these patients,...
Autores principales: | Abu-Helalah, Munir, Azab, Belal, Mubaidin, Rasmi, Ali, Dema, Jafar, Hanan, Alshraideh, Hussam, Drou, Nizar, Awidi, Abdalla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568559/ https://www.ncbi.nlm.nih.gov/pubmed/33067490 http://dx.doi.org/10.1038/s41598-020-74250-2 |
Ejemplares similares
-
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2018) -
Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021) -
Engagement of Jordanian Physicians in Continuous Professional Development: Current Practices, Motivation, and Barriers
por: Younes, Nidal A, et al.
Publicado: (2019) -
Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer
por: Abulkhair, Omalkhair, et al.
Publicado: (2018) -
Patterns and Prevalence of Germline BRCA1 and BRCA2 Mutations among High-Risk Breast Cancer Patients in Jordan: A Study of 500 Patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020)